Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
NuVasive Inc. (NSDQ:NUVA) is looking to turn around a $60 million trademark infringement loss against NeuroVision Medical Products on the grounds that the judge who handled the case "fundamentally misunderstood trademark law" and "exhibited hostility toward NuVasive’s counsel in front of the jury."
Conservative activist Grover Norquist counted the medical device tax as one of President Barack Obama’s top measures that will most hurt seniors.
Health care giant Johnson & Johnson (NYSE:JNJ) found itself again in the hot seat as new reports claim the company sold a transvaginal mesh product in the U.S. for 3 years before obtaining appropriate FDA clearance.